Yes it is same doctor that presented dcvax -
: NYAS New York Academy of Science - DCVax® Phase 3 Final Results
“Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination for Glioblastoma”
Dr. Paul Mulholland, MBBS, MSc, PhD, FRCP
University College Hospital
This study is not related -
A clinical trial for patients newly diagnosed with glioblastoma, an aggressive form of brain cancer, has opened at the NIHR UCLH Clinical Research Facility based in the National Hospital for Neurology and Neurosurgery.
Led by consultant UCLH medical oncologist and UCL honorary associate professor Paul Mulholland, the UCL sponsored Win-Glio trial will recruit 16 patients over an 18-month period.
Patients will receive immunotherapy treatment using the drug ipilimumab, prior to the standard treatment when their immune system is at its strongest.
Following treatment in the trial, patients will go on to have the current standard treatment of surgery where appropriate, radiotherapy and chemotherapy and will receive ongoing monitoring by Dr Mulholland and his team.
This trial follows the NeAT-GLIO clinical trial led by Dr Mulholland and funded by the Jon Moulton Charity Trust that had to close due to lack of recruitment of patients. However, the one patient recruited to that trial is doing well with no active tumour present on scans more than two and half years on from treatment (see case study below).
Market Data 
Markets 
AI
